INTS (Intensity Therapeutics) FFO


INTS Intensity Therapeutics Inc INTS
28 GF Score
Price $4.09
! 1 Warning Sign
View Full Analysis

What is Intensity Therapeutics FFO?

FFO (Funds from operations) only applies to REITs.

INTS
28GF Score
Intensity Therapeutics Inc INTS
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Intensity Therapeutics Business Description

Address 1 Enterprise Drive, Suite 430, Shelton, CT, USA, 06484-4779
Intensity Therapeutics Inc is a late-stage clinical biotechnology company passionately committed to applying scientific leadership in the field of localized cancer reduction to anti-cancer immune activation. Its new approach involves the direct injection into tumors of a product created from DfuseRxSM discovery platform. Its platform creates patented anti-cancer product candidates comprising active anti-cancer agents and amphiphilic molecules. Its product candidate, INT230-6 comprised of three components: cisplatin, a anti-cancer cytotoxic agent, vinblastine sulfate, also a anti-cancer cytotoxic agent, and an amphiphilic molecule which enables the two cytotoxic agents to disperse through a tumor and diffuse into cancer cells following a direct intratumoral injection.
28GF Score

Get the complete analysis for INTS

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.09
Price